MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Eye movement"

  • 2018 International Congress

    Is chronic ocular motor dysfunction in syndrome of antiGAD antibody reversible with immune therapy?

    A. Mook, S. Gunzler, G. Wilmot, A. Shaikh (Cleveland, OH, USA)

    Objective: Is chronic ocular motor dysfunction in syndrome of antiGAD antibody reversible with immune therapy? Background: Increased serum titers of antiGAD antibody can be seen…
  • 2018 International Congress

    Oculomotor Behavior in Healthy Caribbean: Does it reflect an increased vulnerability to degenerative Parkinsonism?

    A. Lannuzel, A. Lackmy, B. Tressières, R. Edragas, V. Pélonde-Erimée, C. Bonnet, S. Rivaud-Péchoux, E. Roze, B. Gaymard (Pointe-à-Pitre, Guadeloupe)

    Objective: To investigate the impact of environmental factors on eye movement performances in two populations composed of carefully selected healthy subjects with strikingly different ethnic…
  • 2018 International Congress

    Update on Convergence Spasm: Review of Psychogenic and Organic Case Reports

    R. Fekete, S. Jankovic (Valhalla, NY, USA)

    Objective: The aim is to evaluate case reports and series of convergence spasm (CS). Background: CS consists of episodes of convergence of the eyes, miosis,…
  • 2018 International Congress

    Using saccades as an early test of levodopa treatment in Parkinson’s Disease

    Z.J. Lu, S. Dillon, P. Zetegren, M. Brzezick, C. Kennard, J. FitzGerald, C. (Oxford, United Kingdom)

    Objective: It is important to know what potential confounding effects the medications used to treat Parkinson’s disease (PD) have on eye movement, in order to…
  • 2018 International Congress

    Eye tracking in patients with restless legs syndrome with and without augmentation – interim results of an ongoing study

    P. Ellmerer, B. Heim, M. Ritter, A. Stefani, E. Brandauer, E. Holzknecht, K. Seppi, B. Högl, W. Poewe, A. Djamshidian (Innsbruck, Austria)

    Objective: To assess the ability to inhibit eye movements towards a target by analysing antisaccades using an eye tracker. Background: Restless legs syndrome (RLS) is…
  • 2018 International Congress

    Study of eye movements by video-oculography in essential tremors

    M. De Verdal, A. Lozza, D. Renard, E. Thouvenot, G. Castelnovo (Nimes, France)

    Objective: To study eye movements by video-oculography (VOG) in ET patients, and to evaluate the possible relationship between oculomotor abnormalities and the hereditary character of…
  • 2018 International Congress

    An oculogyric crisis after administation of alizapride: A tardive phenomenon?

    A. Boogers (Edegem, Belgium)

    Objective: We present a case of an oculogyric crisis (OGC) after administration of alizapride. Curious about this case is that the OGC only happened after…
  • 2018 International Congress

    Eye Movements during Reading in Parkinson’s Disease: A Pilot Study

    J. Waldthaler, P. Tsitsi, G. Öqvist Seimyr, M. Nilsson Benfatto, P. Svenningsson (Marburg, Germany)

    Objective: To characterize eye movements during reading in patients with moderate stage Parkinson's disease (PD) with respect to medication state and cognitive ability. Background: Many…
  • 2018 International Congress

    Reversible asymmetric parkinsonism and vertical gaze limitation as an initial manifestation of dural arteriovenous fistula

    W. Yoon (Seoul, Republic of Korea)

    Objective: Our aim is to report a case of unusual manifestation of dural arteriovenous fistula (DAVF) which showed reversible asymmetric parkinsonism and vertical gaze limitation…
  • 2018 International Congress

    Improvement of antisaccade amplitude by the STN DBS and target eccentricity

    A. Yugeta, Y. Terao, Y. Ugawa (Tokyo, Japan)

    Objective: To investigate the dependency of antisaccade (AS) amplitude improvement by the subthalamic nucleus (STN) deep brain stimulation (DBS) on the target eccentricity in Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 12
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley